Latest News about NVO
Recent news which mentions NVO
This chart gives one reason European stocks may continue to outperform U.S. equities
February 17, 2023
From MarketWatch
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
February 15, 2023
From Benzinga
2 Market-Beating Growth Stocks That Are Just Getting Started
February 10, 2023
From Motley Fool
BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
February 10, 2023
From Benzinga
This nearly 150-year-old fund hasn’t cut its dividend since 1938. Here are the stocks it likes, and four it doesn’t.
February 10, 2023
From MarketWatch
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
February 06, 2023
From Benzinga
The 7 ETFs to Buy for the Perfect Portfolio
February 01, 2023
From InvestorPlace
Novo Nordisk A/s (NVO) Q4 2022 Earnings Call Transcript
February 01, 2023
Tickers
NVO
From Motley Fool
Novo Nordisk Q4 Highlights: Clocks 25% Increase In Sales On Strong Diabetes and Obesity Treatment, Expects 13% - 19% Revenue Growth
February 01, 2023
Tickers
NVO
From Benzinga
Earnings Scheduled For February 1, 2023
February 01, 2023
From Benzinga
Novo Nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts
February 01, 2023
Tickers
NVO
From MarketWatch
7 Healthcare Stocks That Will Be Big Winners in 2023
January 31, 2023
From InvestorPlace
3 Global Stocks to Buy to Get Around America’s Slowdown
January 30, 2023
From InvestorPlace
Mr. Beast Video Highlights Major Problem: Billions Will Need Eyecare According To Report
January 30, 2023
From Benzinga
2 Market-Beating Stocks to Buy in 2023 and Hold for 10 Years
January 26, 2023
From Motley Fool
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
January 25, 2023
From Benzinga
3 Drug Stocks With Promising Pipelines for 2023
January 23, 2023
From InvestorPlace
Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide
January 19, 2023
From Benzinga
From Benzinga
2 Top Biotech Stocks Defying the Bear Market
January 10, 2023
From Motley Fool
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
January 09, 2023
From Benzinga
Jim Cramer Says Avoid This Stock: 'Too Expensive'
January 05, 2023
From Benzinga
Could Eli Lilly Stock Help You Become a Millionaire?
January 05, 2023
From Motley Fool
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
December 24, 2022
From Motley Fool
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
December 20, 2022
From Benzinga
2 Smartest Tech Stocks to Buy in 2022 and Beyond
December 20, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.